Sometimes the more...is not necessarily the better...does the 700 mg. dose of Leronlimab have a tendency to populate greater/last longer...thereby provide more protection on a molecular level.?

We are not talking about the quality of the Molecule...just how far-reaching its effects...age...weight...genetic makeup must play a part in the overall equation.

Encasing/starving the tumor has to have a quantatative effect on how much of the product is left to work. Once it has done its work...does it move on to the next battle...or is it exhausted.?

Not sure if I'm explaining myself properly...not a scientist.